You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

extramedullary lesions

Showing 1 - 25 of 6,357
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Malignancies Trial in Hangzhou (CAR-T cells)

Recruiting
  • Hematological Malignancies
  • CAR-T cells
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Mar 8, 2021

Digital Droplet PCR in Early Period After Allo-HSCT to Predict

Completed
  • Measurable Residual Disease
  • Digital Droplet PCR
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 17, 2023

T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023

Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023

Leukemia, T Cell Trial in Beijing (CD7 CART)

Recruiting
  • Leukemia, T Cell
  • CD7 CART
  • Beijing, Hebei, China
    He bei Yan da Lu dao pei Hospital
May 24, 2022

Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 3, 2022

Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)

Recruiting
  • Multiple Myeloma
  • Shenyang, Liaoning, China
    The First Affiliated Hospital of China Medical University
Jul 6, 2022

Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Changzhou, Jiangsu, China
  • +5 more
Jun 11, 2023

Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

Active, not recruiting
Has Results
  • Plasma Cell Leukemia
  • +2 more
  • Rochester, Minnesota
  • +1 more
May 19, 2022

Myeloma, Multiple, Myeloma-Multiple Trial run by the NCI (Avelumab, External beam radiotherapy)

Terminated
Has Results
  • Myeloma, Multiple
  • Myeloma-Multiple
  • Avelumab
  • External beam radiotherapy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2021

Spinal Cord Tumor Trial in Sohag (surgical excision)

Recruiting
  • Spinal Cord Tumor
  • surgical excision
  • Sohag, Egypt
    Sohag University Hospital
Dec 28, 2022

Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

Not yet recruiting
  • Extramedullary Myeloma
  • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2022

Multiple Myeloma Trial in Shanghai (Human Derived anti-BCMA CAR-T Injection)

Recruiting
  • Multiple Myeloma
  • Human Derived anti-BCMA CAR-T Injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 27, 2022

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • 18F-fluciclovine injection
  • 18F-FDG PET/CT
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 31, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • inotuzumab ozogamicin
  • (no location specified)
Jan 6, 2023

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

People With Multiple Myeloma in Portugal

Recruiting
  • Relapse and/or Refractory Multiple Myeloma
    • Braga, Portugal
    • +7 more
    Jun 9, 2022

    Extramedullary Multiple Myeloma Trial in Wuhan (Selinexor, CT103A)

    Recruiting
    • Extramedullary Multiple Myeloma
    • Wuhan, Hu Bei, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    May 17, 2022

    Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
      • (no location specified)
      Nov 1, 2023

      Extramedullary Acute Myeloid Leukemia: Retrospective Single

      Completed
      • Acute Myeloid Leukemia
      • retrospective data analysis
      • Amman, Jordan
        King Hussein Cancer Center
      Sep 15, 2021

      Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

      Active, not recruiting
      Has Results
      • Myeloid Leukemia, Chronic, Chronic Phase
      • Atlanta, Georgia
      • +85 more
      Jan 4, 2022

      Upper Endoscopy in Ulcerative Colitis Assiut University

      Not yet recruiting
      • Upper Gastrointestinal Disorder
      • Upper endoscopy
      • (no location specified)
      Oct 19, 2023

      Pneumonia, Pneumocystis Trial in Toulouse (Blood sampling, urine sampling)

      Completed
      • Pneumonia, Pneumocystis
      • Blood sampling
      • urine sampling
      • Toulouse, France
        Institut Fédératif de Biologie (IFB), CHU - Hôpital Purpan
      Feb 28, 2022

      Predictive Cancer Model Trial in Prague (colonoscopy)

      Recruiting
      • Predictive Cancer Model
      • colonoscopy
      • Prague, Czechia
        Military University Hospital
      Jun 25, 2023